# Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute Schizophrenia

> **NCT00712686** · PHASE3 · COMPLETED · sponsor: **Otsuka Pharmaceutical Development & Commercialization, Inc.** · enrollment: 690 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Aripiprazole
- **DRUG:** Olanzapine

## Key facts

- **NCT ID:** NCT00712686
- **Lead sponsor:** Otsuka Pharmaceutical Development & Commercialization, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-06
- **Primary completion:** 2003-12
- **Final completion:** 2003-12
- **Target enrollment:** 690 (ACTUAL)
- **Last updated:** 2013-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00712686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00712686, "Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute Schizophrenia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00712686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*